C12Y 207/01068
1-phosphatidylinositol-4-phosphate 5-kinase
Official title: 1-Phosphatidylinositol-4-phosphate 5-kinase (2.7.1.68)
C12Y207/01068 (1-phosphatidylinositol-4-phosphate 5-kinase) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 4
- Assignees
- 4
- Inventors
- 10
- Latest grant
- 5 Jun 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for modulating cholesterol efflux9 Apr 2026US 2026/0097053 A1Cleveland State University
- Cancer therapy23 May 2024US 2024/0167037 A1National University Corporation Kobe University
- New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis6 Oct 2016US 2016/0291016 A1Chu Sainte-Justine
- Antisense modulation of phosphatidylinositol-4-phosphate 5-kinase, Ialpha expression19 Jun 2003US 2003/0114400 A1Isis Pharmaceuticals, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.